Commerce Ministry for imposing anti-dumping duty on pharma API from China
The Hindu
Directorate General of Trade Remedies has recommended the duty after concluding in its probe that the API from China has been exported at dumped prices into India, which impacted the domestic industry.
The Commerce Ministry has recommended imposition of anti-dumping duty on a pharma raw material—Ceftriaxone Sodium Sterile— from China to guard domestic players from cheap imports.
Directorate General of Trade Remedies (DGTR) has recommended the duty after concluding in its probe that the API (active pharma ingredient) from China has been exported at dumped prices into India, which impacted the domestic industry.
"The authority recommends the imposition of the anti-dumping duty on the imports of subject goods...," the directorate has said in a notification.